Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $450M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARENA PHARMACEUTICALS INC | 530,670 | $49.32M | 11.0% | $60.39 | — | COM NEW | 040047607 |
| EXEL | EXELIXIS INC | 1,750,000 | $31.99M | 7.1% | $21.47 | -10.9% | COM | 30161Q104 |
| XENE | XENON PHARMACEUTICALS INC | 950,000 | $29.68M | 6.6% | $20.67 | +44.6% | COM | 98420N105 |
| TVTX | TRAVERE THERAPEUTICS INC | 800,000 | $24.83M | 5.5% | $24.95 | +12.9% | COM | 89422G107 |
| ANAB | ANAPTYSBIO INC | 592,250 | $20.58M | 4.6% | $24.89 | +27.4% | COM | 032724106 |
| VRTX | VERTEX PHARMACEUTICALS INC | 85,000 | $18.67M | 4.1% | $195.24 | -0.4% | COM | 92532F100 |
| BCAB | BIOATLA INC | 864,300 | $16.97M | 3.8% | $38.65 | -33.8% | COM | 09077B104 |
| GLPG | GALAPAGOS NV | 300,000 | $16.54M | 3.7% | $55.13 | — | SPON ADR | 36315X101 |
| RLMD | RELMADA THERAPEUTICS INC | 717,320 | $16.16M | 3.6% | $22.24 | 0.0% | COM | 75955J402 |
| MGNX | MACROGENICS INC | 1,000,000 | $16.05M | 3.6% | $18.17 | +3.6% | COM | 556099109 |
| CYTK | CYTOKINETICS INC | 350,000 | $15.95M | 3.5% | $29.44 | +31.1% | COM NEW | 23282W605 |
| — | TRICIDA INC | 1,400,000 | $13.38M | 3.0% | $4.49 | — | COM | 89610F101 |
| — | RIGEL PHARMACEUTICALS INC | 5,000,000 | $13.25M | 2.9% | $3.25 | — | COM NEW | 766559603 |
| SRPT | SAREPTA THERAPEUTICS INC | 145,405 | $13.09M | 2.9% | $85.49 | 0.0% | COM | 803607100 |
| BCYC | BICYCLE THERAPEUTICS PLC | 200,000 | $12.17M | 2.7% | $60.87 | — | SPONSORED ADS | 088786108 |
| PCVX | VAXCYTE INC | 500,000 | $11.89M | 2.6% | $23.45 | -0.8% | COM | 92243G108 |
| RNAM | AVIDITY BIOSCIENCES INC | 500,000 | $11.88M | 2.6% | $23.88 | 0.0% | COM | 05370A108 |
| ACRS | ACLARIS THERAPEUTICS INC | 800,000 | $11.63M | 2.6% | $15.70 | -3.5% | COM | 00461U105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 500,526 | $10.93M | 2.4% | $38.30 | -28.8% | COM | 77313F106 |
| SLN | SILENCE THERAPEUTICS PLC | 444,443 | $10.62M | 2.4% | $23.89 | — | ADS | 82686Q101 |
| DYN | DYNE THERAPEUTICS INC | 845,000 | $10.05M | 2.2% | $18.15 | -22.6% | COM | 26818M108 |
| — | PASSAGE BIO INC | 1,518,095 | $9.64M | 2.1% | $6.35 | — | COM | 702712100 |
| PRQR | PROQR THRAPEUTICS N V | 1,121,122 | $8.98M | 2.0% | $7.59 | +0.4% | SHS EURO | N71542109 |
| URGN | UROGEN PHARMA LTD | 873,424 | $8.306M | 1.8% | $15.60 | -9.6% | COM | M96088105 |
| — | CHINOOK THERAPEUTICS INC | 390,041 | $6.362M | 1.4% | $16.31 | — | COM | 16961L106 |
| — | KINIKSA PHARMACEUTICALS LTD | 536,738 | $6.317M | 1.4% | $11.43 | — | COM CL A | G5269C101 |
| — | PIERIS PHARMACEUTICALS INC | 1,550,000 | $5.859M | 1.3% | $3.78 | — | COM | 720795103 |
| KALV | KALVISTA PHARMACEUTICALS INC | 411,937 | $5.45M | 1.2% | $15.92 | 0.0% | COM | 483497103 |
| — | MAGENTA THERAPEUTICS INC | 1,170,000 | $5.183M | 1.2% | $9.65 | — | COM | 55910K108 |
| PYXS | PYXIS ONCOLOGY INC | 400,000 | $4.388M | 1.0% | $11.45 | 0.0% | COMMON STOCK | 747324101 |
| — | AEGLEA BIOTHERAPEUTICS INC | 910,251 | $4.324M | 1.0% | $7.47 | — | COM | 00773J103 |
| — | NEKTAR THERAPEUTICS | 203,900 | $2.755M | 0.6% | $17.96 | — | Call | 640268108 |
| ABUS | ARBUTUS BIOPHARMA CORP | 668,907 | $2.602M | 0.6% | $3.88 | 0.0% | COM | 03879J100 |
| CABA | CABALETTA BIO INC | 472,433 | $1.791M | 0.4% | $10.67 | 0.0% | COM | 12674W109 |
| RFL | RAFAEL HLDGS INC | 285,714 | $1.457M | 0.3% | $45.91 | -70.7% | COM CL B | 75062E106 |
| — | POINT BIOPHARMA GLOBAL INC | 190,520 | $1.067M | 0.2% | $5.60 | — | COM | 730541109 |